Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Revenue, Gross Profit, Operating Income (Loss), Depreciation and Amortization Expenses, Accounts Receivable and Inventory by Reportable Segments

Revenue, gross profit, operating income (loss), depreciation and amortization expenses, accounts receivable and inventories by reportable segments were as follows (in thousands):

	Year Ended December 31,
	2023		2022		2021
Revenue
Precision Medicine and Manufacturing	$	282,971	$	274,674	$	232,459
Medical Solutions		325,221		277,992		262,060
Robotics and Automation		273,470		308,237		212,274
Total	$	881,662	$	860,903	$	706,793

	Year Ended December 31,
	2023			2022			2021
Gross Profit
Precision Medicine and Manufacturing	$	139,060		$	129,173		$	107,993
Medical Solutions		135,640			108,713			100,890
Robotics and Automation		130,885			146,150			99,345
Unallocated Corporate and Shared Services		(5,688	)		(5,564	)		(7,900	)
Total	$	399,897		$	378,472		$	300,328

	Year Ended December 31,
	2023			2022			2021
Operating Income (Loss)
Precision Medicine and Manufacturing	$	69,283		$	63,760		$	46,792
Medical Solutions		41,883			28,244			17,694
Robotics and Automation		48,373			60,294			52,676
Unallocated Corporate and Shared Services		(49,043	)		(49,219	)		(53,108	)
Total	$	110,496		$	103,079		$	64,054

	Year Ended December 31,
	2023		2022		2021
Depreciation and Amortization Expenses
Precision Medicine and Manufacturing	$	10,285	$	10,999	$	11,600
Medical Solutions		15,941		17,402		20,812
Robotics and Automation		19,032		24,358		10,728
Unallocated Corporate and Shared Services		1,354		399		254
Total	$	46,612	$	53,158	$	43,394

	December 31,
	2023		2022
Accounts Receivable
Precision Medicine and Manufacturing	$	40,562	$	42,541
Medical Solutions		60,894		53,610
Robotics and Automation		37,954		41,546
Total accounts receivable	$	139,410	$	137,697
Inventories
Precision Medicine and Manufacturing	$	58,492	$	58,630
Medical Solutions		38,440		47,511
Robotics and Automation		52,439		61,856
Total inventories	$	149,371	$	167,997
Total segment assets	$	288,781	$	305,694

	December 31,
	2023		2022
Total Assets
Total segment assets	$	288,781	$	305,694
Cash and cash equivalents		105,051		100,105
Prepaid income taxes and income taxes receivable		8,105		1,508
Prepaid expenses and other current assets		13,360		13,212
Property, plant and equipment, net		109,449		103,186
Operating lease assets		38,302		43,317
Deferred tax assets		27,862		15,113
Other assets		5,617		4,414
Intangible assets, net		145,022		175,766
Goodwill		484,507		478,897
Total	$	1,226,056	$	1,241,212

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer location where products are shipped. Revenue from these customers is summarized as follows (in thousands, except percentage data):

	Year Ended December 31,
	2023					2022					2021
	Revenue		% of Total			Revenue		% of Total			Revenue		% of Total
United States	$	418,265		47.4	%	$	372,345		43.3	%	$	270,833		38.4	%
Germany		128,229		14.5			133,728		15.5			101,865		14.4
Rest of Europe		137,027		15.6			137,803		16.0			138,863		19.6
China		73,444		8.3			97,178		11.3			95,045		13.4
Rest of Asia-Pacific		105,350		12.0			101,596		11.8			89,198		12.6
Other		19,347		2.2			18,253		2.1			10,989		1.6
Total	$	881,662		100.0	%	$	860,903		100.0	%	$	706,793		100.0	%

Summary of Long-lived Assets

Long-lived assets consist of property, plant and equipment, net, and are aggregated based on the location of the assets. A summary of these long-lived assets is as follows (in thousands):

	December 31,
	2023		2022
United States	$	23,899	$	27,488
Germany		35,318		36,545
U.K.		28,734		18,457
Czech Republic		14,100		13,779
China		7,114		6,518
Rest of World		284		399
Total	$	109,449	$	103,186

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

	Year Ended December 31,
	2023			2022			2021
Medical		54	%		49	%		52	%
Advanced Industrial		46	%		51	%		48	%
Total		100	%		100	%		100	%